INTRODUCTION: The Functional Outcomes of Sleep Questionnaire (FOSQ), has been used in research and clinical practice to measure the impact of daytime sleepiness on activities of daily living. The purpose of this study was to develop a shorter version of the instrument (FOSQ-10) that may be more easily implemented in clinical practice. METHODS: Data from a study of CPAP-treated obstructive sleep apnea (OSA) patients (Sample 1) (n = 155, AHI = 63 +/- 31) were used to develop the FOSQ-10. Of the 30 original FOSQ items, 10 questions representing each of the 5 subscales were selected if they had a normal distribution of responses and the largest pre- to post-treatment effect size. The psychometric properties of the instrument were then evaluated with data from a second, independent sample of CPAP-treated OSA patients (n = 51 AH I = 51 +/- 28). RESULTS: Internal consistency of the FOSQ-10 was alpha = 0.87. Pre-treatment correlations of the 2 scales was r = 0.96. After 3 months of treatment the correlation was r = 0.97 (P < 0.0001). Subscales were also highly correlated at baseline and following treatment. Effect sizes for both instruments were highly correlated and indicated ability to measure meaningful change. Differences were observed between scores on the FOSQ-10 for normal controls and OSA patients. CONCLUSIONS: The FOSQ-10 is a psychometrically strong instrument that performs similarly to the long version. The rapidly completed and easily scored FOSQ-10 shows promise for application in the clinical setting.
INTRODUCTION: The Functional Outcomes of Sleep Questionnaire (FOSQ), has been used in research and clinical practice to measure the impact of daytime sleepiness on activities of daily living. The purpose of this study was to develop a shorter version of the instrument (FOSQ-10) that may be more easily implemented in clinical practice. METHODS: Data from a study of CPAP-treated obstructive sleep apnea (OSA) patients (Sample 1) (n = 155, AHI = 63 +/- 31) were used to develop the FOSQ-10. Of the 30 original FOSQ items, 10 questions representing each of the 5 subscales were selected if they had a normal distribution of responses and the largest pre- to post-treatment effect size. The psychometric properties of the instrument were then evaluated with data from a second, independent sample of CPAP-treated OSA patients (n = 51 AH I = 51 +/- 28). RESULTS: Internal consistency of the FOSQ-10 was alpha = 0.87. Pre-treatment correlations of the 2 scales was r = 0.96. After 3 months of treatment the correlation was r = 0.97 (P < 0.0001). Subscales were also highly correlated at baseline and following treatment. Effect sizes for both instruments were highly correlated and indicated ability to measure meaningful change. Differences were observed between scores on the FOSQ-10 for normal controls and OSA patients. CONCLUSIONS: The FOSQ-10 is a psychometrically strong instrument that performs similarly to the long version. The rapidly completed and easily scored FOSQ-10 shows promise for application in the clinical setting.
Authors: C Monasterio; S Vidal; J Duran; M Ferrer; C Carmona; F Barbé; M Mayos; N Gonzalez-Mangado; M Juncadella; A Navarro; R Barreira; F Capote; L R Mayoralas; G Peces-Barba; J Alonso; J M Montserrat Journal: Am J Respir Crit Care Med Date: 2001-09-15 Impact factor: 21.405
Authors: Maree Barnes; Danielle Houston; Christopher J Worsnop; Alister M Neill; Ivanka J Mykytyn; Amanda Kay; John Trinder; Nicholas A Saunders; R Douglas McEvoy; Robert J Pierce Journal: Am J Respir Crit Care Med Date: 2002-03-15 Impact factor: 21.405
Authors: Rachel D Wells; Kenneth E Freedland; Robert M Carney; Stephen P Duntley; Edward J Stepanski Journal: Psychosom Med Date: 2007-06-07 Impact factor: 4.312
Authors: Samuel T Kuna; David Shuttleworth; Luqi Chi; Sharon Schutte-Rodin; Eliot Friedman; Hengyi Guo; Sandeep Dhand; Lin Yang; Jingsan Zhu; Scarlett L Bellamy; Kevin G Volpp; David A Asch Journal: Sleep Date: 2015-08-01 Impact factor: 5.849
Authors: Harneet K Walia; Nicolas R Thompson; Irene Katzan; Nancy Foldvary-Schaefer; Douglas E Moul; Reena Mehra Journal: J Clin Sleep Med Date: 2017-11-15 Impact factor: 4.062
Authors: Cathy A Alessi; Constance H Fung; Joseph M Dzierzewski; Lavinia Fiorentino; Carl Stepnowsky; Juan C Rodriguez Tapia; Yeonsu Song; Michelle R Zeidler; Karen Josephson; Michael N Mitchell; Stella Jouldjian; Jennifer L Martin Journal: Sleep Date: 2021-04-09 Impact factor: 5.849
Authors: Patrick J Strollo; M Boyd Gillespie; Ryan J Soose; Joachim T Maurer; Nico de Vries; Jason Cornelius; Ronald D Hanson; Tapan A Padhya; David L Steward; B Tucker Woodson; Johan Verbraecken; Olivier M Vanderveken; Mark G Goetting; Neil Feldman; Frédéric Chabolle; M Safwan Badr; Winfried Randerath; Kingman P Strohl Journal: Sleep Date: 2015-10-01 Impact factor: 5.849